Loss of Proapoptotic Bcl-2-Related Multidomain Proteins in Primary Melanomas Is Associated with Poor Prognosis
- 1 June 2006
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (6) , 1366-1371
- https://doi.org/10.1038/sj.jid.5700192
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodesLaboratory Investigation, 2005
- Selective Induction of Apoptosis in Melanoma Cells by Tyrosinase Promoter-Controlled CD95 Ligand OverexpressionJournal of Investigative Dermatology, 2005
- Impact of Ulceration in Stages I to III Cutaneous Melanoma As Staged by the American Joint Committee on Cancer Staging System: An Analysis of the German Central Malignant Melanoma RegistryJournal of Clinical Oncology, 2004
- CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplantsOncogene, 2003
- Guardians of cell death: the Bcl-2 family proteinsEssays in Biochemistry, 2003
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- The kiss of death: promises and failures of death receptors and ligands in cancer therapyLeukemia, 2001
- Epidemiology of Cutaneous Melanoma in Germany and WorldwideSkin Pharmacology and Physiology, 2001
- bax, but notbcl-2, influences the prognosis of human pancreatic cancerGut, 1998
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970